After 75 Years of Methotrexate, Can Treatment Results Be Improved With Appropriate Folinic Acid Rescue?
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31608 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Ian J Cohen. Beteiligte Einrichtung: The Rina Zaizov Dept of Pediatric Hematology Oncology, The Schneider Children's Hospital of Israel, Petah Tikva and the Sackler Faculty of Medicine, …. Hauptthemen laut MEDLINE: Methotrexate, Leucovorin, Antimetabolites, Antineoplastic, Folic Acid Antagonists. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
After 75 years of clinical use of folic acid antagonists such as methotrexate, relevant pharmacological data currently important for the effective and safe use of methotrexate were reviewed to see if it is possible to improve outcomes. Specifically, to improve how high‐dose methotrexate (HD‐MTX) can be given safely, what doses of MTX (methotrexate) are adequate to achieve therapeutic levels, and what is the appropriate folinic acid (FA) dose for effective rescue. This review is based on 50 years of personal experience with the use of HD‐MTX in published literature. Many pharmacologic studies were performed over 50 years ago, but are still relevant and stand up to scrutiny today. What should be considered HD‐MTX and how it can be given safely and effectively without late toxicity are presented. The variables responsible for effective folinic acid rescue, especially the doses of MTX and folinic acid and the time to start of rescue, are discussed. Understanding these highlighted aspects of therapy could help to prevent acute toxicity, improve treatment results, and prevent late effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Rina Zaizov Dept of Pediatric Hematology Oncology, The Schneider Children's Hospital of Israel, Petah Tikva and the Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
ORCID-Profile: Ian J Cohen
Zitieren
APA
Cohen, I. J. (2025). After 75 Years of Methotrexate, Can Treatment Results Be Improved With Appropriate Folinic Acid Rescue?. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31608
Vancouver
Cohen IJ. After 75 Years of Methotrexate, Can Treatment Results Be Improved With Appropriate Folinic Acid Rescue?. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31608
BibTeX
@article{Cohen2025,
author = {Cohen, Ian J},
title = {After 75 Years of Methotrexate, Can Treatment Results Be Improved With Appropriate Folinic Acid Rescue?},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31608}
}
EUVIMED